Cargando…
Single step method for high yield human platelet lysate production
BACKGROUND: We aimed to develop a single step method for the production of human platelet lysate (hPL). The method must result in high hPL yields, be closed system and avoid heparin use. STUDY DESIGN AND METHODS: The method aimed at using glass beads and calcium. An optimal concentration of calcium...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099704/ https://www.ncbi.nlm.nih.gov/pubmed/36426732 http://dx.doi.org/10.1111/trf.17188 |
_version_ | 1785025111529619456 |
---|---|
author | Delabie, Willem De Bleser, Dominique Vandewalle, Vicky Vandekerckhove, Philippe Compernolle, Veerle Feys, Hendrik B. |
author_facet | Delabie, Willem De Bleser, Dominique Vandewalle, Vicky Vandekerckhove, Philippe Compernolle, Veerle Feys, Hendrik B. |
author_sort | Delabie, Willem |
collection | PubMed |
description | BACKGROUND: We aimed to develop a single step method for the production of human platelet lysate (hPL). The method must result in high hPL yields, be closed system and avoid heparin use. STUDY DESIGN AND METHODS: The method aimed at using glass beads and calcium. An optimal concentration of calcium and glass beads was determined by serial dilution. This was translated to a novel method and compared to known methods: freeze‐thawing and high calcium. Quality outcome measures were transmittance, fibrinogen and growth factor content, and cell doubling time. RESULTS: An optimal concentration of 5 mM Ca(2+) and 0.2 g/ml glass beads resulted in hPL with yields of 92% ± 1% (n = 50) independent of source material (apheresis or buffy coat‐derived). The transmittance was highest (56% ± 9%) compared to known methods (<39%). The fibrinogen concentration (7.0 ± 1.1 μg/ml) was well below the threshold, avoiding the need for heparin. Growth factor content was similar across hPL production methods. The cell doubling time of adipose derived stem cells was 25 ± 1 h and not different across methods. Batch consistency was determined across six batches of hPL (each n = 25 constituting concentrates) and was <11% for all parameters including cell doubling time. Calcium precipitation formed after 4 days of culturing stem cells in media with hPL prepared by the high (15 mM) Ca(2+) method, but not with hPL prepared by glass bead method. DISCUSSION: The novel method transforms platelet concentrates to hPL with little hands‐on time. The method results in high yield, is closed system, without heparin and non‐inferior to published methods. |
format | Online Article Text |
id | pubmed-10099704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100997042023-04-14 Single step method for high yield human platelet lysate production Delabie, Willem De Bleser, Dominique Vandewalle, Vicky Vandekerckhove, Philippe Compernolle, Veerle Feys, Hendrik B. Transfusion Cellular Therapies BACKGROUND: We aimed to develop a single step method for the production of human platelet lysate (hPL). The method must result in high hPL yields, be closed system and avoid heparin use. STUDY DESIGN AND METHODS: The method aimed at using glass beads and calcium. An optimal concentration of calcium and glass beads was determined by serial dilution. This was translated to a novel method and compared to known methods: freeze‐thawing and high calcium. Quality outcome measures were transmittance, fibrinogen and growth factor content, and cell doubling time. RESULTS: An optimal concentration of 5 mM Ca(2+) and 0.2 g/ml glass beads resulted in hPL with yields of 92% ± 1% (n = 50) independent of source material (apheresis or buffy coat‐derived). The transmittance was highest (56% ± 9%) compared to known methods (<39%). The fibrinogen concentration (7.0 ± 1.1 μg/ml) was well below the threshold, avoiding the need for heparin. Growth factor content was similar across hPL production methods. The cell doubling time of adipose derived stem cells was 25 ± 1 h and not different across methods. Batch consistency was determined across six batches of hPL (each n = 25 constituting concentrates) and was <11% for all parameters including cell doubling time. Calcium precipitation formed after 4 days of culturing stem cells in media with hPL prepared by the high (15 mM) Ca(2+) method, but not with hPL prepared by glass bead method. DISCUSSION: The novel method transforms platelet concentrates to hPL with little hands‐on time. The method results in high yield, is closed system, without heparin and non‐inferior to published methods. John Wiley & Sons, Inc. 2022-11-25 2023-02 /pmc/articles/PMC10099704/ /pubmed/36426732 http://dx.doi.org/10.1111/trf.17188 Text en © 2022 The Authors. Transfusion published by Wiley Periodicals LLC on behalf of AABB. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Cellular Therapies Delabie, Willem De Bleser, Dominique Vandewalle, Vicky Vandekerckhove, Philippe Compernolle, Veerle Feys, Hendrik B. Single step method for high yield human platelet lysate production |
title | Single step method for high yield human platelet lysate production |
title_full | Single step method for high yield human platelet lysate production |
title_fullStr | Single step method for high yield human platelet lysate production |
title_full_unstemmed | Single step method for high yield human platelet lysate production |
title_short | Single step method for high yield human platelet lysate production |
title_sort | single step method for high yield human platelet lysate production |
topic | Cellular Therapies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099704/ https://www.ncbi.nlm.nih.gov/pubmed/36426732 http://dx.doi.org/10.1111/trf.17188 |
work_keys_str_mv | AT delabiewillem singlestepmethodforhighyieldhumanplateletlysateproduction AT debleserdominique singlestepmethodforhighyieldhumanplateletlysateproduction AT vandewallevicky singlestepmethodforhighyieldhumanplateletlysateproduction AT vandekerckhovephilippe singlestepmethodforhighyieldhumanplateletlysateproduction AT compernolleveerle singlestepmethodforhighyieldhumanplateletlysateproduction AT feyshendrikb singlestepmethodforhighyieldhumanplateletlysateproduction |